Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,746.40
(
1.07%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
110.35
(
-1.80%
)
Bitcoin
76,317.96
(
0.71%
)
News Focus
News Focus
Post# of 257473
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122916
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 244373

Tuesday, 02/21/2023 12:14:23 PM

Tuesday, February 21, 2023 12:14:23 PM

Post# of 257473
PFE’s maternal RSV vaccine has Aug 2023 PDUFA—(with_FDA_priority_review):

https://finance.yahoo.com/news/u-fda-accepts-biologics-license-114500315.html

In data reported in Nov 2022, one of two primary endpoints was met, but PFE said this was sufficient for FDA approval (#msg-170339033).

GSK terminated its own program for a maternal RSV vaccine, so PFE will have the only maternal RSV vaccine on the market if this BLA is approved.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today